Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Relay Therapeutics (RLAY) Shares Outstanding: 2020-2024

Historic Shares Outstanding for Relay Therapeutics (RLAY) over the last 5 years, with Dec 2024 value amounting to $167.8 million.

  • Relay Therapeutics' Shares Outstanding rose 3.44% to $172.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $172.6 million, marking a year-over-year increase of 3.44%. This contributed to the annual value of $167.8 million for FY2024, which is 31.61% up from last year.
  • As of FY2024, Relay Therapeutics' Shares Outstanding stood at $167.8 million, which was up 31.61% from $127.5 million recorded in FY2023.
  • In the past 5 years, Relay Therapeutics' Shares Outstanding registered a high of $167.8 million during FY2024, and its lowest value of $89.9 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding was $127.5 million (2023), whereas its average is $138.8 million.
  • Data for Relay Therapeutics' Shares Outstanding shows a peak YoY skyrocketed of 31.61% (in 2024) over the last 5 years.
  • Over the past 5 years, Relay Therapeutics' Shares Outstanding (Yearly) stood at $89.9 million in 2020, then climbed by 20.36% to $108.2 million in 2021, then grew by 11.92% to $121.1 million in 2022, then rose by 5.24% to $127.5 million in 2023, then spiked by 31.61% to $167.8 million in 2024.